MassBio is excited to announce that registration is now open for its annual meeting, the State of Possible Conference, which will be hosted online on May 19, 2021. The free, interactive event will draw hundreds of leaders from across the life sciences in Massachusetts and beyond to celebrate how the life sciences continues to make the impossible possible for patients across the world.
“Over the past year, we’ve seen the Massachusetts live sciences community do what it does best: making patient lives better by advancing transformative solutions,” said Kendalle Burlin O’Connell, President & COO, MassBio. “Massachusetts’ outsized role in the global fight against COVID-19 cements our position as the center of gravity for the industry. Through the State of Possible Conference, we’re proud to provide a platform for life sciences stakeholder to convene, reflect, and catalyze future innovation.”
The 2021 edition of the State of Possible Conference will feature the industry’s brightest minds in engaging conversations on the latest industry developments, key insights from the past year, and strategies to build a better future together. Through keynotes, panel discussions, and Possible Talks®, the agenda will cover topics ranging from new funding pathways for emerging biopharmas to the evolution of clinical trials.
“For more than a year, we have been inundated with unprecedented loss and hardship, but despite this turmoil, the life sciences industry demonstrated its true value in addressing the world’s greatest unmet medical needs,” said Chuck Wilson, Chair, MassBio’s Board of Directors. “The pandemic is not over yet, and we still have many hurdles ahead, but the State of Possible Conference provides a unique and significant opportunity to come together and celebrate the growth of the life sciences as we prepare for the future.”
Interested attendees can register for free on the State of Possible event page.
2021 State of Possible sponsors include: BeiGene, Corealis Pharma, Mispro Biotech Services, Morgan Stanley, PTC Therapeutics, Sunovion Pharmaceuticals, Takeda, and Thermo Fisher Scientific.